FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the field of pharmaceutical industry, in particular to the use of a therapeutically effective amount of a salt of 2-ethyl-6-methyl-3-hydroxypyridine with fumaric acid of the formula: 
for treatment of disease caused by oxidative stress and selected from the group that includes Parkinson’s disease, Alzheimer's disease, Huntington’s chorea, retinitis pigmentosa, mitochondrial encephalomyopathy, multiple sclerosis, stroke, Crohn's disease, ulcerative colitis, rheumatoid arthritis, psoriasis.
EFFECT: invention provides an expansion of the means for treatment of diseases caused by oxidative stress, and increasing the effectiveness of such treatment.
7 cl, 2 dwg, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DPP3-BINDING MOLECULE AIMED AT SPECIFIC DPP3 EPITOPES AND BINDING TO THEM AND ITS USE FOR PREVENTION OR TREATMENT OF DISEASES/ACUTE CONDITIONS, WHICH ARE RELATED TO OXIDATIVE STRESS | 2018 |
|
RU2787033C2 |
| USE OF LACTOBACILLUS FERMENTUM U-21 STRAIN CELLS FOR PREVENTION OF PATHOLOGIC TISSUE CHANGE CAUSED BY OXIDATIVE STRESS | 2019 |
|
RU2757118C2 |
| DRUG FOR TREATING ENDOMETRIOSIS | 2022 |
|
RU2818816C1 |
| LACTOBACILLUS FERMENTUM U-21 STRAIN, WHICH PRODUCES COMPLEX OF BIOLOGICALLY ACTIVE SUBSTANCES WHICH NEUTRALIZE SUPEROXIDE ANION INDUCED BY CHEMICAL AGENTS | 2018 |
|
RU2705250C2 |
| METHOD FOR PREVENTING AND CORRECTING METABOLIC AND FUNCTIONAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM UNDER STRESS CONDITIONS | 2019 |
|
RU2717107C1 |
| 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SALT WITH CARNITINE HYDRATE, HAVING ANTIOXIDANT ACTIVITY, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2817094C1 |
| COMBINATION TO REDUCE OXIDATIVE STRESS IN THE BODY AND MAINTAIN LIVER FUNCTIONS | 2020 |
|
RU2762824C1 |
| 4-(3-((2-ADAMANTYL)AMINO)-3-OXOPROP-1-EN-1-YL)-N-HYDROXYBENZAMIDE - A NEW DRUG FOR THE TREATMENT OF ALZHEIMER'S DISEASE | 2022 |
|
RU2783995C1 |
| HERBAL REMEDY WITH ANTIOXIDANT EFFECT | 2022 |
|
RU2794091C1 |
| BICYCLIC PYRIMIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS - ANTIOXIDANT PROGRAMME ACTIVATORS AND USING THEM AS CYTOPROTECTORS | 2014 |
|
RU2545758C1 |
